Stockreport

Rigel Pharmaceuticals Inc (RIGL) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ... [Yahoo! Finance]

Rigel Pharmaceuticals, Inc.  (RIGL) 
Last rigel pharmaceuticals, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.rigel.com
PDF TAVALISSE Net Product Sales: $26.3 million, an 8% increase from Q3 2023. REZLIDHIA Net Product Sales: $5.5 million, a 107% increase from Q3 2023. Contract Revenues [Read more]